METHYLPHENIDATE INTERVIEWS IN PSYCHOTHERAPY
Abstract
1. The use of oral methylphenidate to potentiate interviews in 16 office psychotherapy patients was studied for a period of one year. Results indicate that in patients with fixed neurotic processes it can speed the therapeutic progress.
2. The drug gave no physical complications in 16 healthy subjects in doses that were two to four times that ordinarily prescribed. Dosages ranged from 40 to 80 mg. orally per dose.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).